Summary
44 / 100 · Bulios Score
What speaks for it
- Revenue grew by 11% a year over the last 3 years.
- It has been profitable 6 years in a row.
What to watch
- Earnings per share fell by 37% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
- Out of every 100 EUR of revenue, only 2.3 EUR is left as net profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 21.9 EUR for 1 EUR of yearly profit. Over the last five years it was 24.8 EUR on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (EUR)
Diluted EPS (EUR)
Revenue fell by 3.1% a year over 5 years. Over the last 3 years it grew by 11% a year. Earnings per share fell by 37% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 EUR of revenue goes
- Cost of sales 0.0 EUR
- Sales and administration 7.4 EUR
- Taxes and other 90 EUR
- Net profit 2.3 EUR
Net profit, industry median (Insurance - Life) 11 EUR
Out of every 100 EUR of revenue, 2.3 EUR is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Moderate, at risk- Yield
- 4.26%
- Paid out of profit
- 93%
- Raised in a row
- 3 years
You receive $0.38 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.